New index could revolutionize how hospitals measure gastric cancer surgery success
NCT ID NCT07180966
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 32 times
Summary
This study aims to create a new tool called the SAH Index to fairly evaluate gastric cancer surgery results. Researchers will analyze data from 780 patients who had surgery in 2019, looking at factors like age, tumor type, and genetic markers. The goal is to help hospitals compare surgical outcomes more accurately, but this study does not test any new treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER (GC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ruijin Hospital Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China
Conditions
Explore the condition pages connected to this study.